190 related articles for article (PubMed ID: 17718259)
1. Immunohistochemical study for the diagnosis of Alport's syndrome.
Wongtrakul P; Shayakul C; Parichatikanond P; Suthipinittharm P; Amjaroen C; Kaewkaukul N; Vongirad A; Ongajyooth L
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S171-81. PubMed ID: 17718259
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
[TBL] [Abstract][Full Text] [Related]
3. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
4. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
[TBL] [Abstract][Full Text] [Related]
5. Immunofluorescence study of type IV collagen alpha chains in epidermal basement membrane: application in diagnosis of X-linked Alport syndrome.
Ding J; Yang J; Liu J; Yu L
Chin Med J (Engl); 1997 Aug; 110(8):584-6. PubMed ID: 9594257
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant Alport's syndrome: study of a large Tunisian family.
Kharrat M; Makni S; Makni K; Kammoun K; Charfeddine K; Azaeiz H; Jarraya F; Ben Hmida M; Gubler MC; Ayadi H; Hachicha J
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):320-5. PubMed ID: 16970251
[TBL] [Abstract][Full Text] [Related]
7. Detection of mutations in the COL4A5 gene in over 90% of male patients with X-linked Alport's syndrome by RT-PCR and direct sequencing.
Inoue Y; Nishio H; Shirakawa T; Nakanishi K; Nakamura H; Sumino K; Nishiyama K; Iijima K; Yoshikawa N
Am J Kidney Dis; 1999 Nov; 34(5):854-62. PubMed ID: 10561141
[TBL] [Abstract][Full Text] [Related]
8. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
[TBL] [Abstract][Full Text] [Related]
9. [Collagen alpha5 and alpha2 (IV) chain coexpression: The procedure of choice to diagnose Alport syndrome from skin biopsies].
Patey-Mariaud de Serre N; Noël LH
Ann Pathol; 2008 Jun; 28(3):182-6. PubMed ID: 18706356
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical diagnosis of Alport's syndrome in paraffin-embedded renal sections: antigen retrieval with autoclave heating.
Naito I; Ninomiya Y; Nomura S
Med Electron Microsc; 2003 Mar; 36(1):1-7. PubMed ID: 12658346
[TBL] [Abstract][Full Text] [Related]
11. Siblings with Alport's syndrome showing unique staining patterns for alpha5(IV) and alpha6(IV) chains of collagen type IV.
Tsuji T; Fujigaki Y; Sakakima M; Sado Y; Hishida A
Clin Exp Nephrol; 2010 Jun; 14(3):283-7. PubMed ID: 20213338
[TBL] [Abstract][Full Text] [Related]
12. Type VII collagen in Alport syndrome.
Giannakakis K; Massella L; Grassetti D; Dotta F; Perez M; Muda AO
Nephrol Dial Transplant; 2007 Dec; 22(12):3501-7. PubMed ID: 17670768
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane.
Heikkilä P; Tibell A; Morita T; Chen Y; Wu G; Sado Y; Ninomiya Y; Pettersson E; Tryggvason K
Gene Ther; 2001 Jun; 8(11):882-90. PubMed ID: 11423936
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
Chen N; Pan X; Ren H; Dong D
Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
[TBL] [Abstract][Full Text] [Related]
15. Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: mRNA levels, protein expression and urinary loss.
Sanna-Cherchi S; Carnevali ML; Martorana D; Cravedi P; Maggiore U; Alinovi R; Bovino A; Mattei S; Orlandini G; Gatti R; Savi M; Sado Y; Neri TM; Allegri L
Am J Nephrol; 2007; 27(2):129-37. PubMed ID: 17308374
[TBL] [Abstract][Full Text] [Related]
16. [Alport's syndrome: apropos of 2 families].
Grünfeld JP
Nephrologie; 2000; 21(6):295-8. PubMed ID: 11117109
[TBL] [Abstract][Full Text] [Related]
17. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
18. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
19. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
